1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea
- Catalog No. :
- ACCOJM025
- CAS No. :
- 1561178-17-3
- Molecular Formula :
- C28H40BrN7O4
- Molecular Weight :
- 618.58
IUPAC Name:1-(3-((((2R,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$54.00Login to see priceIn stockInquiry
10mg99%$95.00Login to see priceIn stockInquiry
25mg99%$219.00Login to see priceIn stockInquiry
50mg99%$264.00Login to see priceIn stockInquiry
100mg99%$525.00Login to see priceInquiryInquiry
250mg99%$888.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | 1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea |
|---|---|
| IUPAC Name | 1-(3-((((2R,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea |
| Molecular Formula | C28H40BrN7O4 |
| Molecular Weight | 618.58 |
| SMILES | NC1=NC=NC2=C1C(Br)=CN2[C@H]3[C@H](O)[C@H](O)[C@@H](CN(CCCNC(NC4=CC=C(C(C)(C)C)C=C4)=O)C(C)C)O3 |
| InChI Key | IQCKJUKAQJINMK-HUBRGWSESA-N |
| Synonym | 1561178-17-3 | SGC0946 | SGC 0946 | SGC-0946 | 1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-7-[ |
| CAS No. | 1561178-17-3 |
| PubChem CID | 56962337 |
Safety Data
- Pictogram
- Signal Word
- Danger
- Hazard Statement(s)
- H301
- Precautionary Statement(s)
- P301+P310

